PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Health In Tech, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Health In Tech, Inc.'s yearly results (2022–2025), compared with Technology companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Debt Due Cover Ratio: Debt due within a year is covered 41.1 times by its yearly operating cash. Higher than 87% of Technology companies in United States.
  • Cash Cushion Ratio: Cash, after subtracting all debt, equals 20% of its market value (net cash). Higher than 86% of Technology companies in United States.

Where $100 of sales goes

$95Operating costs$0.0Interest$3.8Net profit

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

$155

Over the last 3 years, every $100 of reported profit came with $155 of operating cash.

Lower than 54% of Technology companies in United States.

Self-Funding Ratio

1.3×

Over the last 3 years its own operating cash covered its investment spending (capex) 1.3 times.

Lower than 65% of Technology companies in United States.

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

3/3 · 2/3

Sales grew in 3 of the last 3 years; profit grew in 2 of 3.

Steadier than 75% of Technology companies in United States.

Growth Efficiency Ratio

$4

Sales grew 478% in 3 years; of every extra $100 of sales, $4 became extra profit.

Lower than 68% of Technology companies in United States.

Asset Productivity Ratio

+478% / -19%

In 3 years sales changed by +478% while total assets changed by -19%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

41.1×

Debt due within a year is covered 41.1 times by its yearly operating cash.

Higher than 87% of Technology companies in United States.

Cash Cushion Ratio

+20%

Cash, after subtracting all debt, equals 20% of its market value (net cash).

Higher than 86% of Technology companies in United States.

Tangible Assets Ratio

72%

Of every $100 the company owns, $72 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 53% of Technology companies in United States.

Tangible Net Worth Ratio

62%

Of every $100 of net worth, $62 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 58% of Technology companies in United States.

Shareholders

Shareholder Slice Ratio

+7%

Share count rose 7% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 52% of Technology companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Health In Tech, Inc. made a loss over the last year. Health In Tech, Inc. owes $0.34 for every $1 it owns. Net profit rose 91% in the year to Dec 2025, and grew 152% a year on average over 3 years.

Compared with Technology companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Health In Tech, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

1.92

The share price is 1.92 times Health In Tech, Inc.'s book value per share, lower than 69% of Technology companies in United States.

Market cap

$38 M

The total market value of all of Health In Tech, Inc.'s shares at today's price (share price × number of shares), smaller than 85% of Technology companies in United States. PosiCap size class: Micro Cap.

Net worth (book value)

$20 M

What Health In Tech, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$0.30

Net worth divided by the number of shares. The share price of $0.58 is 1.9 times this, which is the P/B above.

Return on equity (ROE)

-21.9%

Health In Tech, Inc. lost 21.9% of its shareholders' money over the last year, lower than 73% of Technology companies in United States.

Owes vs Owns

0.34×

Health In Tech, Inc. owes $0.34 for every $1 it owns (low), lower than 66% of Technology companies in United States.

Dividend yield

None

Health In Tech, Inc. does not currently pay a dividend.

Revenue growth

+71%

Revenue rose 71% in the year to Dec 2025, and grew 79% a year on average over 3 years.

Profit growth

+91%

Net profit rose 91% in the year to Dec 2025, and grew 152% a year on average over 3 years.

Profit margin

3.8%

Health In Tech, Inc. keeps $4 of every $100 of revenue as net profit.

Cash quality

2.5×

Cash from Health In Tech, Inc.'s business was 2.5× its reported profit in the year to Dec 2025 — its profit turned into cash.

Cash vs debt

Net cash

Health In Tech, Inc. held $8 M more cash than debt (net cash) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Health In Tech, Inc.: $38 M ÷ $20 M (30 Jun 2026) = 1.9.

What is Health In Tech, Inc.'s return on equity?

Health In Tech, Inc. lost 21.9% of its shareholders' money over the last year, lower than 73% of Technology companies in United States.

How much does Health In Tech, Inc. owe compared with what it owns?

Health In Tech, Inc. owes $0.34 for every $1 it owns (low), lower than 66% of Technology companies in United States.

Does Health In Tech, Inc. pay a dividend?

No. Health In Tech, Inc. does not currently pay a dividend.

Is Health In Tech, Inc.'s revenue growing?

Revenue rose 71% in the year to Dec 2025, and grew 79% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.